The announcement of a groundbreaking drug by San Francisco biotech company Loyal marks a potential milestone in veterinary medicine. The drug‚ LOY-001‚ is on the brink of approval by the U.S. Food and Drug Administration (FDA) for extending the life of large-breed dogs. According to Loyal’s CEO and founder‚ Celine Halioua‚ “There are 25 million… The post Revolutionary Anti-Aging Drug Will Extend Lifespan of Large-Breed Dogs Nears FDA Approval appeared first on The Federalist Papers.